HEADER IMMUNE SYSTEM 03-AUG-01 1JPY TITLE CRYSTAL STRUCTURE OF IL-17F CAVEAT 1JPY NAG A 241 HAS WRONG CHIRALITY AT ATOM C1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: INTERLEUKIN 17F; COMPND 3 CHAIN: A, B, X, Y; COMPND 4 FRAGMENT: SECRETED IL-17F; COMPND 5 SYNONYM: IL-17F; COMPND 6 ENGINEERED: YES; COMPND 7 OTHER_DETAILS: THE FIRST FOUR RESIDUES, GSHM, ARE FROM THE VECTOR SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: IL-17F; SOURCE 6 EXPRESSION_SYSTEM: UNIDENTIFIED BACULOVIRUS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 10469; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: HI5 CELLS; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID KEYWDS CYSTINE-KNOT, CYTOKINE, T-CELL DERIVED, DIMER, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR S.G.HYMOWITZ,E.H.FILVAROFF,J.YIN,J.LEE,L.CAI,P.RISSER,M.MARUOKA, AUTHOR 2 W.MAO,J.FOSTER,R.KELLEY,G.PAN,A.L.GURNEY,A.M.DE VOS,M.A.STAROVASNIK REVDAT 5 29-JUL-20 1JPY 1 CAVEAT COMPND REMARK SEQADV REVDAT 5 2 1 HETNAM LINK SITE ATOM REVDAT 4 13-JUL-11 1JPY 1 VERSN REVDAT 3 24-FEB-09 1JPY 1 VERSN REVDAT 2 03-FEB-04 1JPY 1 JRNL REMARK REVDAT 1 28-SEP-01 1JPY 0 JRNL AUTH S.G.HYMOWITZ,E.H.FILVAROFF,J.P.YIN,J.LEE,L.CAI,P.RISSER, JRNL AUTH 2 M.MARUOKA,W.MAO,J.FOSTER,R.F.KELLEY,G.PAN,A.L.GURNEY, JRNL AUTH 3 A.M.DE VOS,M.A.STAROVASNIK JRNL TITL IL-17S ADOPT A CYSTINE KNOT FOLD: STRUCTURE AND ACTIVITY OF JRNL TITL 2 A NOVEL CYTOKINE, IL-17F, AND IMPLICATIONS FOR RECEPTOR JRNL TITL 3 BINDING. JRNL REF EMBO J. V. 20 5332 2001 JRNL REFN ISSN 0261-4189 JRNL PMID 11574464 JRNL DOI 10.1093/EMBOJ/20.19.5332 REMARK 2 REMARK 2 RESOLUTION. 2.85 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 98.1 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.85 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.200 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 10000000.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 19202 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : SHELLS REMARK 3 R VALUE (WORKING SET) : 0.238 REMARK 3 FREE R VALUE : 0.284 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.900 REMARK 3 FREE R VALUE TEST SET COUNT : 1127 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.008 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.85 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.03 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2992 REMARK 3 BIN R VALUE (WORKING SET) : 0.3180 REMARK 3 BIN FREE R VALUE : 0.3770 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.60 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 178 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.028 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3725 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 89 REMARK 3 SOLVENT ATOMS : 27 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 63.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 47.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.22000 REMARK 3 B22 (A**2) : 0.22000 REMARK 3 B33 (A**2) : -0.44000 REMARK 3 B12 (A**2) : -0.25000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.36 REMARK 3 ESD FROM SIGMAA (A) : 0.42 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.43 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.48 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.012 REMARK 3 BOND ANGLES (DEGREES) : 1.600 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 28.70 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.870 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 3.690 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 6.240 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 4.150 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 6.090 ; 2.500 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : PARAM19.SOL REMARK 3 PARAMETER FILE 3 : PARAM19.ION REMARK 3 PARAMETER FILE 4 : PARAM3.CHO REMARK 3 PARAMETER FILE 5 : PARAM.SO4 REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : TOPHCSDX.PRO REMARK 3 TOPOLOGY FILE 2 : TOP19.ION REMARK 3 TOPOLOGY FILE 3 : PARAM19.SOL REMARK 3 TOPOLOGY FILE 4 : PARAM3.CHO REMARK 3 TOPOLOGY FILE 5 : PARAM.SO4 REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 THE STRUCTURE WAS SOLVED USING DATA COLLECTED AT THREE DIFFERENT REMARK 3 WAVELENGHTS FROM CRYSTALS THAT HAD BEEN SOAKED IN THE HG CONTAINING REMARK 3 COMPOUND THIMEROSAL BUT WAS REFINED AGAINST A NATIVE DATA SET REMARK 3 COLLECTED ON A CRYSTAL THAT WAS NOT DERIVATIZED. THE REMARK 3 CRYSTOLLGRAPHIC REMARK 3 STATISTICS PRESENTED HERE ARE FOR THE NATIVE DATA SET. USED REMARK 3 MAXIMUM REMARK 3 LIKELIHOOD RESIDUAL. THE PROGRAM REFMAC WAS USED AT THE INITIAL REMARK 3 STAGES REMARK 3 OF REFINEMENT. REMARK 3 REMARK 3 A BULK SOLVENT CORRECTIONS WAS APPLIED IN XPLOR98.1 AS PART OF THE REMARK 3 REFINEMENT PROCESS. THIS CORRECTION HAS NOT BEEN APPLIED TO THE REMARK 3 DEPOSITTED STRUCTURE FACTORS REMARK 4 REMARK 4 1JPY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-AUG-01. REMARK 100 THE DEPOSITION ID IS D_1000014050. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-MAR-01 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL9-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9790 REMARK 200 MONOCHROMATOR : SSRL BEAM LINE 9-2 REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : BLU-ICE REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19294 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.850 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 7.300 REMARK 200 R MERGE (I) : 0.08800 REMARK 200 R SYM (I) : 0.08800 REMARK 200 FOR THE DATA SET : 7.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.85 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.95 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 7.30 REMARK 200 R MERGE FOR SHELL (I) : 0.54100 REMARK 200 R SYM FOR SHELL (I) : 0.54100 REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: MLPHARE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 64.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.30 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: WELL SOLUTION CONSISTED OF 1.0M REMARK 280 LITHIUM SULFATE, 0.5M AMMONIUM SULFATE, 100MM SODIUM CITRATE, 1% REMARK 280 ETHANOL AT 5.6, VAPOR DIFFUSION, HANGING DROP AT 292K, PH 5.6 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 65 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+1/6 REMARK 290 6555 X-Y,X,Z+5/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 59.94267 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 29.97133 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 44.95700 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 14.98567 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 74.92833 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICALLY ACTIVE UNIT IS A DIMER. THE ASSYMETRIC REMARK 300 UNIT IS FORMED OF TWO DIMERS. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 7270 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14090 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -39.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 7580 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13790 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -55.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: X, Y, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -3 REMARK 465 SER A -2 REMARK 465 HIS A -1 REMARK 465 MET A 0 REMARK 465 ARG A 1 REMARK 465 LYS A 2 REMARK 465 ILE A 3 REMARK 465 PRO A 4 REMARK 465 LYS A 5 REMARK 465 VAL A 6 REMARK 465 GLY A 7 REMARK 465 ILE A 129 REMARK 465 HIS A 130 REMARK 465 HIS A 131 REMARK 465 VAL A 132 REMARK 465 GLN A 133 REMARK 465 GLY B -3 REMARK 465 SER B -2 REMARK 465 HIS B -1 REMARK 465 MET B 0 REMARK 465 ARG B 1 REMARK 465 LYS B 2 REMARK 465 ILE B 3 REMARK 465 PRO B 4 REMARK 465 LYS B 5 REMARK 465 VAL B 6 REMARK 465 GLY B 7 REMARK 465 ILE B 129 REMARK 465 HIS B 130 REMARK 465 HIS B 131 REMARK 465 VAL B 132 REMARK 465 GLN B 133 REMARK 465 GLY X -3 REMARK 465 SER X -2 REMARK 465 HIS X -1 REMARK 465 MET X 0 REMARK 465 ARG X 1 REMARK 465 LYS X 2 REMARK 465 ILE X 3 REMARK 465 PRO X 4 REMARK 465 LYS X 5 REMARK 465 VAL X 6 REMARK 465 GLY X 7 REMARK 465 HIS X 8 REMARK 465 PRO X 19 REMARK 465 VAL X 20 REMARK 465 PRO X 21 REMARK 465 ILE X 129 REMARK 465 HIS X 130 REMARK 465 HIS X 131 REMARK 465 VAL X 132 REMARK 465 GLN X 133 REMARK 465 GLY Y -3 REMARK 465 SER Y -2 REMARK 465 HIS Y -1 REMARK 465 MET Y 0 REMARK 465 ARG Y 1 REMARK 465 LYS Y 2 REMARK 465 ILE Y 3 REMARK 465 PRO Y 4 REMARK 465 LYS Y 5 REMARK 465 PRO Y 19 REMARK 465 VAL Y 20 REMARK 465 PRO Y 21 REMARK 465 GLY Y 22 REMARK 465 GLY Y 23 REMARK 465 HIS Y 131 REMARK 465 VAL Y 132 REMARK 465 GLN Y 133 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 HIS B 8 CG ND1 CD2 CE1 NE2 REMARK 470 PRO Y 18 CG CD REMARK 470 HIS Y 130 CG ND1 CD2 CE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 16 33.51 -65.93 REMARK 500 PRO A 21 -115.07 4.56 REMARK 500 ILE A 86 12.67 -65.59 REMARK 500 HIS A 104 -173.22 69.53 REMARK 500 SER B 16 39.15 -66.63 REMARK 500 PRO B 19 155.97 -49.99 REMARK 500 HIS B 104 173.81 71.26 REMARK 500 SER B 108 39.70 -87.50 REMARK 500 GLU X 15 -38.85 -38.69 REMARK 500 ARG X 47 0.32 -61.65 REMARK 500 HIS X 104 -155.13 61.27 REMARK 500 HIS Y 104 -160.90 53.53 REMARK 500 ILE Y 129 38.65 -91.84 REMARK 500 REMARK 500 REMARK: NULL DBREF 1JPY A 1 133 GB 15077800 AAK83350 31 163 DBREF 1JPY B 1 133 GB 15077800 AAK83350 31 163 DBREF 1JPY X 1 133 GB 15077800 AAK83350 31 163 DBREF 1JPY Y 1 133 GB 15077800 AAK83350 31 163 SEQADV 1JPY GLY A -3 GB 15077800 EXPRESSION TAG SEQADV 1JPY SER A -2 GB 15077800 EXPRESSION TAG SEQADV 1JPY HIS A -1 GB 15077800 EXPRESSION TAG SEQADV 1JPY MET A 0 GB 15077800 EXPRESSION TAG SEQADV 1JPY GLY B -3 GB 15077800 EXPRESSION TAG SEQADV 1JPY SER B -2 GB 15077800 EXPRESSION TAG SEQADV 1JPY HIS B -1 GB 15077800 EXPRESSION TAG SEQADV 1JPY MET B 0 GB 15077800 EXPRESSION TAG SEQADV 1JPY GLY X -3 GB 15077800 EXPRESSION TAG SEQADV 1JPY SER X -2 GB 15077800 EXPRESSION TAG SEQADV 1JPY HIS X -1 GB 15077800 EXPRESSION TAG SEQADV 1JPY MET X 0 GB 15077800 EXPRESSION TAG SEQADV 1JPY GLY Y -3 GB 15077800 EXPRESSION TAG SEQADV 1JPY SER Y -2 GB 15077800 EXPRESSION TAG SEQADV 1JPY HIS Y -1 GB 15077800 EXPRESSION TAG SEQADV 1JPY MET Y 0 GB 15077800 EXPRESSION TAG SEQRES 1 A 137 GLY SER HIS MET ARG LYS ILE PRO LYS VAL GLY HIS THR SEQRES 2 A 137 PHE PHE GLN LYS PRO GLU SER CYS PRO PRO VAL PRO GLY SEQRES 3 A 137 GLY SER MET LYS LEU ASP ILE GLY ILE ILE ASN GLU ASN SEQRES 4 A 137 GLN ARG VAL SER MET SER ARG ASN ILE GLU SER ARG SER SEQRES 5 A 137 THR SER PRO TRP ASN TYR THR VAL THR TRP ASP PRO ASN SEQRES 6 A 137 ARG TYR PRO SER GLU VAL VAL GLN ALA GLN CYS ARG ASN SEQRES 7 A 137 LEU GLY CYS ILE ASN ALA GLN GLY LYS GLU ASP ILE SER SEQRES 8 A 137 MET ASN SER VAL PRO ILE GLN GLN GLU THR LEU VAL VAL SEQRES 9 A 137 ARG ARG LYS HIS GLN GLY CYS SER VAL SER PHE GLN LEU SEQRES 10 A 137 GLU LYS VAL LEU VAL THR VAL GLY CYS THR CYS VAL THR SEQRES 11 A 137 PRO VAL ILE HIS HIS VAL GLN SEQRES 1 B 137 GLY SER HIS MET ARG LYS ILE PRO LYS VAL GLY HIS THR SEQRES 2 B 137 PHE PHE GLN LYS PRO GLU SER CYS PRO PRO VAL PRO GLY SEQRES 3 B 137 GLY SER MET LYS LEU ASP ILE GLY ILE ILE ASN GLU ASN SEQRES 4 B 137 GLN ARG VAL SER MET SER ARG ASN ILE GLU SER ARG SER SEQRES 5 B 137 THR SER PRO TRP ASN TYR THR VAL THR TRP ASP PRO ASN SEQRES 6 B 137 ARG TYR PRO SER GLU VAL VAL GLN ALA GLN CYS ARG ASN SEQRES 7 B 137 LEU GLY CYS ILE ASN ALA GLN GLY LYS GLU ASP ILE SER SEQRES 8 B 137 MET ASN SER VAL PRO ILE GLN GLN GLU THR LEU VAL VAL SEQRES 9 B 137 ARG ARG LYS HIS GLN GLY CYS SER VAL SER PHE GLN LEU SEQRES 10 B 137 GLU LYS VAL LEU VAL THR VAL GLY CYS THR CYS VAL THR SEQRES 11 B 137 PRO VAL ILE HIS HIS VAL GLN SEQRES 1 X 137 GLY SER HIS MET ARG LYS ILE PRO LYS VAL GLY HIS THR SEQRES 2 X 137 PHE PHE GLN LYS PRO GLU SER CYS PRO PRO VAL PRO GLY SEQRES 3 X 137 GLY SER MET LYS LEU ASP ILE GLY ILE ILE ASN GLU ASN SEQRES 4 X 137 GLN ARG VAL SER MET SER ARG ASN ILE GLU SER ARG SER SEQRES 5 X 137 THR SER PRO TRP ASN TYR THR VAL THR TRP ASP PRO ASN SEQRES 6 X 137 ARG TYR PRO SER GLU VAL VAL GLN ALA GLN CYS ARG ASN SEQRES 7 X 137 LEU GLY CYS ILE ASN ALA GLN GLY LYS GLU ASP ILE SER SEQRES 8 X 137 MET ASN SER VAL PRO ILE GLN GLN GLU THR LEU VAL VAL SEQRES 9 X 137 ARG ARG LYS HIS GLN GLY CYS SER VAL SER PHE GLN LEU SEQRES 10 X 137 GLU LYS VAL LEU VAL THR VAL GLY CYS THR CYS VAL THR SEQRES 11 X 137 PRO VAL ILE HIS HIS VAL GLN SEQRES 1 Y 137 GLY SER HIS MET ARG LYS ILE PRO LYS VAL GLY HIS THR SEQRES 2 Y 137 PHE PHE GLN LYS PRO GLU SER CYS PRO PRO VAL PRO GLY SEQRES 3 Y 137 GLY SER MET LYS LEU ASP ILE GLY ILE ILE ASN GLU ASN SEQRES 4 Y 137 GLN ARG VAL SER MET SER ARG ASN ILE GLU SER ARG SER SEQRES 5 Y 137 THR SER PRO TRP ASN TYR THR VAL THR TRP ASP PRO ASN SEQRES 6 Y 137 ARG TYR PRO SER GLU VAL VAL GLN ALA GLN CYS ARG ASN SEQRES 7 Y 137 LEU GLY CYS ILE ASN ALA GLN GLY LYS GLU ASP ILE SER SEQRES 8 Y 137 MET ASN SER VAL PRO ILE GLN GLN GLU THR LEU VAL VAL SEQRES 9 Y 137 ARG ARG LYS HIS GLN GLY CYS SER VAL SER PHE GLN LEU SEQRES 10 Y 137 GLU LYS VAL LEU VAL THR VAL GLY CYS THR CYS VAL THR SEQRES 11 Y 137 PRO VAL ILE HIS HIS VAL GLN MODRES 1JPY ASN A 53 ASN GLYCOSYLATION SITE MODRES 1JPY ASN B 53 ASN GLYCOSYLATION SITE MODRES 1JPY ASN X 53 ASN GLYCOSYLATION SITE MODRES 1JPY ASN Y 53 ASN GLYCOSYLATION SITE HET NAG C 1 14 HET NDG C 2 14 HET NAG D 1 14 HET NAG D 2 14 HET NAG A 241 14 HET SO4 X 243 5 HET NAG Y 241 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM NDG 2-ACETAMIDO-2-DEOXY-ALPHA-D-GLUCOPYRANOSE HETNAM SO4 SULFATE ION FORMUL 5 NAG 5(C8 H15 N O6) FORMUL 5 NDG C8 H15 N O6 FORMUL 8 SO4 O4 S 2- FORMUL 10 HOH *27(H2 O) HELIX 1 1 HIS A 8 GLN A 12 5 5 HELIX 2 2 ASN A 43 SER A 48 1 6 HELIX 3 3 GLN A 105 VAL A 109 5 5 HELIX 4 4 VAL B 20 SER B 24 5 5 HELIX 5 5 ASN B 43 SER B 48 1 6 HELIX 6 6 ASN Y 43 SER Y 48 1 6 HELIX 7 7 GLN Y 105 VAL Y 109 5 5 SHEET 1 A 8 ARG A 62 TYR A 63 0 SHEET 2 A 8 ASN A 89 LYS A 103 -1 N VAL A 100 O TYR A 63 SHEET 3 A 8 SER A 110 VAL A 125 -1 O SER A 110 N LYS A 103 SHEET 4 A 8 MET B 25 ILE B 32 1 O LYS B 26 N PHE A 111 SHEET 5 A 8 SER A 24 ILE A 32 -1 N MET A 25 O LEU B 27 SHEET 6 A 8 SER B 110 VAL B 125 1 O PHE B 111 N ASP A 28 SHEET 7 A 8 GLU B 84 LYS B 103 -1 O ASN B 89 N VAL B 125 SHEET 8 A 8 ARG B 62 TYR B 63 -1 O TYR B 63 N VAL B 100 SHEET 1 B 8 ARG A 62 TYR A 63 0 SHEET 2 B 8 ASN A 89 LYS A 103 -1 N VAL A 100 O TYR A 63 SHEET 3 B 8 SER A 110 VAL A 125 -1 O SER A 110 N LYS A 103 SHEET 4 B 8 MET B 25 ILE B 32 1 O LYS B 26 N PHE A 111 SHEET 5 B 8 SER A 24 ILE A 32 -1 N MET A 25 O LEU B 27 SHEET 6 B 8 SER B 110 VAL B 125 1 O PHE B 111 N ASP A 28 SHEET 7 B 8 GLU B 84 LYS B 103 -1 O ASN B 89 N VAL B 125 SHEET 8 B 8 GLY B 76 ILE B 78 -1 O CYS B 77 N ASP B 85 SHEET 1 C 2 TRP A 52 TRP A 58 0 SHEET 2 C 2 GLU A 66 CYS A 72 -1 O VAL A 67 N THR A 57 SHEET 1 D 2 CYS A 77 ILE A 78 0 SHEET 2 D 2 GLU A 84 ASP A 85 -1 N ASP A 85 O CYS A 77 SHEET 1 E 2 TRP B 52 TRP B 58 0 SHEET 2 E 2 GLU B 66 CYS B 72 -1 N VAL B 67 O THR B 57 SHEET 1 F 2 MET X 25 LEU X 27 0 SHEET 2 F 2 MET Y 25 LEU Y 27 -1 O MET Y 25 N LEU X 27 SHEET 1 G 2 TRP X 52 TRP X 58 0 SHEET 2 G 2 GLU X 66 CYS X 72 -1 N VAL X 67 O THR X 57 SHEET 1 H 3 ARG X 62 TYR X 63 0 SHEET 2 H 3 ASN X 89 LYS X 103 -1 N VAL X 100 O TYR X 63 SHEET 3 H 3 SER X 110 VAL X 125 -1 O SER X 110 N LYS X 103 SHEET 1 I 2 CYS X 77 ILE X 78 0 SHEET 2 I 2 GLU X 84 ASP X 85 -1 N ASP X 85 O CYS X 77 SHEET 1 J 2 TRP Y 52 TRP Y 58 0 SHEET 2 J 2 GLU Y 66 CYS Y 72 -1 O VAL Y 67 N THR Y 57 SHEET 1 K 3 ARG Y 62 TYR Y 63 0 SHEET 2 K 3 ASN Y 89 LYS Y 103 -1 N VAL Y 100 O TYR Y 63 SHEET 3 K 3 SER Y 110 VAL Y 125 -1 O SER Y 110 N LYS Y 103 SHEET 1 L 2 CYS Y 77 ILE Y 78 0 SHEET 2 L 2 GLU Y 84 ASP Y 85 -1 N ASP Y 85 O CYS Y 77 SSBOND 1 CYS A 17 CYS B 107 1555 1555 2.04 SSBOND 2 CYS A 72 CYS A 122 1555 1555 2.04 SSBOND 3 CYS A 77 CYS A 124 1555 1555 2.03 SSBOND 4 CYS A 107 CYS B 17 1555 1555 2.04 SSBOND 5 CYS B 72 CYS B 122 1555 1555 2.04 SSBOND 6 CYS B 77 CYS B 124 1555 1555 2.02 SSBOND 7 CYS X 17 CYS Y 107 1555 1555 2.03 SSBOND 8 CYS X 72 CYS X 122 1555 1555 2.04 SSBOND 9 CYS X 77 CYS X 124 1555 1555 2.02 SSBOND 10 CYS X 107 CYS Y 17 1555 1555 2.03 SSBOND 11 CYS Y 72 CYS Y 122 1555 1555 2.03 SSBOND 12 CYS Y 77 CYS Y 124 1555 1555 2.03 LINK ND2 ASN A 53 C1 NAG A 241 1555 1555 1.47 LINK ND2 ASN B 53 C1 NAG C 1 1555 1555 1.46 LINK ND2 ASN X 53 C1 NAG D 1 1555 1555 1.46 LINK ND2 ASN Y 53 C1 NAG Y 241 1555 1555 1.46 LINK O4 NAG C 1 C1 NDG C 2 1555 1555 1.40 LINK O4 NAG D 1 C1 NAG D 2 1555 1555 1.38 CISPEP 1 TYR A 63 PRO A 64 0 -0.17 CISPEP 2 TYR B 63 PRO B 64 0 -0.13 CISPEP 3 TYR X 63 PRO X 64 0 -1.42 CISPEP 4 TYR Y 63 PRO Y 64 0 -0.13 CRYST1 126.438 126.438 89.914 90.00 90.00 120.00 P 65 24 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007909 0.004566 0.000000 0.00000 SCALE2 0.000000 0.009133 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011122 0.00000